HAP 819: Advanced StatisticsLecture: Multiplicative Regression
Assigned Reading
AssignmentSubmit one file for all questions. Include all charts, code, and output in the same file. Start each question in a separate page or sheet. Include in the first page a summary page. In the summary page write statements comparing your work to answers given or videos. For example, "I got the same answers as the Teach One video for question 1." Question 1: Estimate mortality rate in 6 months for lung cancer patients with various common comorbidities.
Resources for Question 1:
Question 2: Many patients, at end of life, experience disabilities. In fact, disabilities are often used to anticipate end of life. The attached data show the disabilities residents of veteran administration nursing homes have experienced. Estimate how various disabilities predict mortality in 6 months. The data do not have headers. The variables are listed in the following order: ID, age, gender (M for male, F for Female), number of assessments completed on the person, number of days followed, days since first assessment, days to last assessment, unable to eat, unable to transfer, unable to groom, unable to toilet, unable to bathe, unable to walk, unable to dress, unable to bowel, unable to urine, dead (1) or alive (0), and assessment number. The following table should assist in organizing the data.
Following resources are available for Question 2:
Question 3: These data come from STAR*D experiment conducted by National Institute of Medicine. Use instructor's last name as password. The data report the experience of approximately 4,000 patients receiving various antidepressants: citalopram, bupropion, mirzapine, buspirone, lithium, nortriptyline, sertraline, thyroid, tranylclypromine, and venlafaxine. The data are reported for a total of 22,254 visits. Visits may be 2 weeks or more apart. Not every patient shows for every scheduled visit. Organize the data so there is one row for each patient and each antidepressant trial (known in the data as Concat). Note that this field considers combination of antidepressants as a new antidepressant. Ignore the dose of the medication. Patients received multiple antidepressants during these trials until something worked for them. Include each time a new antidepressant was tried as a separate trial. If the patient has taken the antidepressant at any time during the trial, then mark it as 1, otherwise 0. Notice that some patients have taken the medication and others have not. Patients who have not taken a particular medication have taken other medications, so at any time we are comparing one medication to alternative treatments. The medication is considered to have caused the remission if the patient is referred to follow up portion of the study, i.e., the variable "Treatment_plan_equal_3" is set to 1.
Resources for Question 3:
MoreFor additional information (not part of the required reading), please see the following links:
This page is part of the course on Comparative Effectiveness by Farrokh Alemi PhD Home► Email► |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||